Skip to main content
SpringerLink
Log in

Testicular cancer and the legacy of chemotherapy

  • Review
  • Testicular Cancer, Chemotherapy
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The treatment of testicular cancer has undergone considerable evolution since the introduction of cisplatin and the widespread recognition of its curative potential in all stages of disease. Chemotherapy developments that have taken place include substitution of etoposide for vinblastine in some primary combinations and high-dose cisplatin regimens for patients with otherwise poor prognosis. Definition of timed survival restaging and reassessment of the role of radiation has taken place. In early disease stages, dissection of retroperitoneal nodes combined with either a short course of adjuvant chemotherapy or careful monitoring followed by salvage chemotherapy has yielded impressive results (>90% cures) in node positive patients. These results have encouraged trials including careful follow up for patients with negative retroperitoneal and other findings (markers, computerized tomography) on clinical staging alone. Evolution of these treatment strategies should take place within the context of prospectively designed studies. In this brief overview of developments, we point out how the legacy from the successful application of chemotherapy will form the basis for additional achievements which will include the introduction of secondgeneration drugs and optimization of combined modality strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmed M, Slayton RS (1980) Report on drug-induced pericarditis. Cancer Treat Rep 64: 353

    Google Scholar 

  2. Ball D, Barrett A, Peckham MJ (1982) The management of metastatic seminoma of the testis. Cancer 50: 2289–2294

    Google Scholar 

  3. Barrett A, Hendry WF, McElwain TJ, Peckham MJ (1980) In: van-Oosterom AT, Muggia FM, Cleton FT (eds). Therapeutic progress in ovarian cancer, testicular cancer and the sarcomas. Nijhoff, The Hague, p 181 (Boerhaave series vol 16)

    Google Scholar 

  4. Braun DL, Green MD, Rausen AR, David R, Wolman SR Greco MA, Muggia FM (1981) Down's syndrome and testicular cancer: A possible association. Am J Pediat Hematol Oncol in Press

  5. Catane R, Schwade JG, Turrisi AT, Weber BL, Muggia FM (1979) Pulmonary toxicity after radiation and bleomycin — A review. Int J Radiat Oncol Biol Phys 5: 1513–1518

    Google Scholar 

  6. Cockburn A, Vugrin D, Macchia R Warden S, Whitmore W Jr (1983) Concerning the emergence of new malignancies in patients treated for germ cell tumors of the testis. Proc Am Soc Clin Oncol 2: 139

    Google Scholar 

  7. Comis RL, Tinsley RW, Newman N, Issel BF (1984) The interchain between etoposide and cisplatin in small-cell lung cancer. In: Issell BF, Muggia FM, Carter SK (eds). Etoposide: Current status and new developments. Academic, New York, pp 199–208

    Google Scholar 

  8. Cortes-Funes H, Leiva O, Merdiole C, Mendez C, Moyano A (1982) Cisplatin, vinblastine and bleomycin combination chemotherapy for advanced germ cell tumors. In: Cortes-Funes H, Rosenzweig M (eds) New approaches in cancer therapy Raven, New York, pp 81–93

    Google Scholar 

  9. DeWys WD, Begg C, Slayton R, Hahn RG, Brodsky I (1979) chemotherapy of advanced germinal cell neoplasms: Preliminary report of an Eastern Cooperative Oncology Group. Study. Cancer Treat Rep 63: 1675–1680

    Google Scholar 

  10. DeWys WD, Green SB, Hahn RG, et al. (1984) Selection of testicular cancer patients for a protocol omitting retroperitoneal node dissection. Proc Am Soc Clin Oncol 3: 157

    Google Scholar 

  11. Drasga RE, Einhorn LH, Williams WD, Patel DN, Stevens EE (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 1: 179–183

    Google Scholar 

  12. Einhorn LH (1981) Testicular cancer as a model for a curable neoplasm: The Richard and Hilda Rosenthal Foundation Award Lecture. Cancer Res 41: 3275–3280

    Google Scholar 

  13. Einhorn LH, Donohue JP (1977) cis-Diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med. 87: 293–298

    Google Scholar 

  14. Einhorn LH, Williams SD, Troner M, Birch R, Greco FA (1981) The role of maintenance chemotherapy in disseminated testicular cancer. N Engl J Med 305: 727–731

    Google Scholar 

  15. Feun LG, Samson MK, Stevens RL (1980) Vinblastine, bleomycin, cisdiammine dichloroplatinum in disseminated extragonadal germ cell tumors: A Southwest Oncology Group Study. Cancer 45: 2543–9

    Google Scholar 

  16. Fourth International Adjuvant Therapy Cancer Meeting (1984), March: Proceedings

  17. Garnick MB, Canellos GP, Richie JP (1983) Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. JAMA 250: 1733–1741

    Google Scholar 

  18. Golbey RB (1980) The VAB schemas of treatment for germ cell tumors. In: A Van Oosterom, Muggia FM, Cleton F (eds) Therapeutic progress in ovarian cancer, testicular cancer and three sacromas. Nijhoff, The Hague, pp 203–210

    Google Scholar 

  19. Goldiner PL, Schweizer O (1979) The hazards of anesthesia and surgery in bleomycin treated patients. Semin Oncol 6: 121–124

    Google Scholar 

  20. Hainsworth JD, Einhorn LH, Williams SD, Stewart M, Greco FA (1982) Advanced extragonadel germ cell tumors: Successful treatment with combination chemotherapy. Ann Intern Med 97: 7–11

    Google Scholar 

  21. Hainsworth JD, Greco FA, Williams SD, Einhorn LH (1984) VP-16 in the treatment of refractory germinal neoplasms. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide: current status and new developments. Academic, New York, pp 243–252

    Google Scholar 

  22. Horwich A, Peckman MJ (1984) In: Issell BF, Muggia FM, Carter SK (eds) Etoposide: current status and new developments. Academic, New York, pp 233–242

    Google Scholar 

  23. Jain KK, Bosl GJ, Bains MS, Whitmore WF, Golbey RB (1984) The treatment of extragonadal seminoma. J Clin Oncol 2: 820–827

    Google Scholar 

  24. Javadpour N, Ozols RF, Anderson T, Barlock AB, Wesley R, Young RC (1982) Randomized trial of cytoreductive surgery followed by chemotherapy versus chemotherapy alone in bulky stage III testicular cancer with poor prognostic factors. Cancer 50: 2004–2010

    Google Scholar 

  25. Lederman GS, Garnick MB, Canellos GP, Richie JP (1983) Chemotherapy of refractory germ cell cancer with etoposide. J Clin Oncol 11: 706–709

    Google Scholar 

  26. Li FP, Connelly RR, Myers M (1982) Improved survival rates among testis cancer patients in the United States. JAMA 247: 825–826

    Google Scholar 

  27. Morse M, Herr H, Sogani P, Bosl G, Whitmore W (1983) Surgical exploration of metastatic seminoma following VAB-V1 chemotherapy. Proc Am Soc Clin Oncol 2: 143

    Google Scholar 

  28. Muggia FM, Jacobs EM (1978) Chemotherapy of testicular cancer: Impact on curability. In: Carter SK, Goldin A, Kuretani K, Mathé G, Sakurai Y, Tsukagoshi S, Umezawa H (eds) Advances in cancer chemotherapy. Japan Science Society Press, Tokyo University Park Press, Baltimore, pp 437–452

    Google Scholar 

  29. Ozols KF, Gordon BJ, Jacob J, Wesley MN, Ostrabega Y, Young RC (1984a) High dose cisplatin in hypertonic saline. Ann Intern Med 100: 19–24

    Google Scholar 

  30. Ozols RF, Ihde D, Jacob J, Steis R, Veach SR, Wesley M, Young RC (1984b) Randomized trial of PVeBV versus PVeB in poor-prognosis non-seminomatous tumors. Proc Am Soc Clin Oncol 155

  31. Peckham MJ, Husband JE, Barrett A, Hendry MF (1982) Orchidectomy alone in testicular stage I non-seminomatous germ cell tumors. Lancet II: 678–680

    Google Scholar 

  32. Pizzocaro G (1983) Discussion at ASCO, 1983

  33. Reynolds TF, Yagoda A, Golbey R, et al (1979) Chemotherapy of mediastinal germ-cell tumors. Semin Oncol 6: 113–115

    Google Scholar 

  34. Sakurai Y (1978) Keynote lecture. Development of the concept of experimental chemotherapy in Japan. In: Carter SK, Goldin A, Kuretani K, Mathé G, Sakurai Y, Tsukagoshi S, Umezawa H (eds) Advances in cancer chemotherapy. Japan Science Society Press, Tokyo University Park Press, Baltimore, pp 3–10

    Google Scholar 

  35. Samson MK, Stephens RL, Rivkin S, Opipari N, Malaney T, Grope CW, Fisher R (1979). Vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in disseminated testicular cancer: Preliminary report of a Southwest Oncology Group Study. Cancer Treat Rep 63: 1663–1667

    Google Scholar 

  36. Samson MK, Rivkin SE, Jones SE, et al (1984) Dose-response and dose-survival advantage for high versus low dose cis-platin combined with vinblastine and bleomycin in disseminated testicular cancer. Cancer 53: 1029–1035

    Google Scholar 

  37. Scheulen ME, Pfeiffer P, Hofteen K, Niederle N, Seeber S, Schmidt CG (1984) Long-term survival and prognostic factors in patients with disseminated testicular carcinoma. Proc Am Soc Clin Oncol 3: 163

    Google Scholar 

  38. Seeber S, Scheulen ME, Schilcher RB, et al (1980) Sequential combination chemotherapy with vinblastine-bleomycin and adriamycin cis-platinum in early and late testicular cancer. In: Prestaykol A, Crooke ST, Carter SK (eds) cis-Platinum: current status and new developments. Academic, New York, pp 329–344

    Google Scholar 

  39. Sogani PC, Whitmore WF, Herr HW, Bosl GJ, Golbey RB, Watson RC, De Cosse JJ (1984) Orchiectomy alone in the treatment of clinical stage I non-seminomatous germ cell tumor of the testis. J Clin Oncol 2: 267–270

    Google Scholar 

  40. Sonntag RW, Senn HJ, Cavalli R (1979) Cancer Treat Rep 63: 1669–1679

    Google Scholar 

  41. Stoter A, Vendrika CPS, Struyvenburg A, Brouwers TM, Sleyfer DT, Schrafford-Koops H, van Oosterom RT, Pinedo HM (1980) An update of the dutch multicenter PVB — Study in disseminated testicular non-seminomas. In: Van Oosterom A, Muggia FM, Cleton F (eds) Therapeutic progress in ovarian cancer, testicular cancer and the sarcomas. Nijhoff, The Hague, pp 240–252 (Also published in Lancet I: 941–945

    Google Scholar 

  42. Sturgeon JFG, Herman JG, Jewett MAS, et al (1983) A plicy of surveillance alone after orchidectomy for clinical stage I non-seminomatous testis tumors. Proc Am Soc Clin Oncol 2: 142

    Google Scholar 

  43. Torti FM, Krikorian J, Daniels J, Master D, Cumes D, Spaulding J, Blane C, Chate L (1981) Platinum vinblastine, and bleomcyin induction without maintenance therapy in testicular carcinoma. Proc AACR/ASCO 22: 473 (Abstract C-550)

    Google Scholar 

  44. Torti FM, Shortliffe LD, Rouse RV, et al (1984) Surgery after chemotherapy for advanced germ cell tumors. Proc Am Soc Clin Oncol 3: 160

    Google Scholar 

  45. Tseng A Jr, Kessler R, Freiha F, Broder S, Rothman C, Torti FM (1984) Male fertility before and after treatment of testicular cancer. Proc Am Soc Clin Oncol 3: 161

    Google Scholar 

  46. Van Hoesel QGCM, Pinedo HM (1980) Complete remission of mediastinal germ-cell tumors with cis-dichlorodiammineplatinum (II) combination chemotherapy. Cancer Treat Rep 64: 319–321

    Google Scholar 

  47. Vogelzang NJ, Fraley EE, Lange PH, Torkelson J, Levitt S, Kennedy BJ (1983) Stage II non-seminomatous testicular cancer: A 10-year experience. J Clin Oncol 1: 171–178

    Google Scholar 

  48. Vugrin D, Herr HW, Whitmore WF, Jr, Sogani PC, Golbey RB (1981) VAB-6 combination chemotherapy in disseminated cancer of the testis. Ann Intern Med 95: 59–61

    Google Scholar 

  49. Williams SD, Loehrer PJ, Einhorn LH, Birch R (1984) Testicular cancer: Role of chemotherapy. In: Issell BF, Muggia FM, Carter SK (eds) Etoposide: Current status and new developments. New York, pp 225–232

Download references

Author information

Authors and Affiliations

  1. Rita & Stanley H. Kaplan Cancer Center, New York University Medical Center, 10016, New York, NY, USA

    Franco M. Muggia

Authors
  1. Franco M. Muggia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muggia, F.M. Testicular cancer and the legacy of chemotherapy. Cancer Chemother. Pharmacol. 15, 1–5 (1985). https://doi.org/10.1007/BF00257284

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257284

Keywords

Search

Navigation